Sunrise Medical
Sunrise Medical, a leading name in the mobility and rehabilitation industry, is headquartered in the United Kingdom. Founded in 1983, the company has established itself as a pioneer in providing innovative solutions for individuals with mobility challenges. With a strong presence across Europe, North America, and Asia, Sunrise Medical focuses on designing and manufacturing high-quality wheelchairs, seating systems, and mobility aids. The company’s core products, including powered and manual wheelchairs, are distinguished by their advanced technology and user-centric design, ensuring comfort and independence for users. Notable achievements include numerous industry awards for product innovation and a commitment to sustainability in manufacturing processes. As a trusted partner in the mobility sector, Sunrise Medical continues to enhance the quality of life for individuals worldwide.
DitchCarbon Score
How does Sunrise Medical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Sunrise Medical's score of 13 is lower than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Sunrise Medical's reported carbon emissions
In 2023, Sunrise Medical reported total carbon emissions of approximately 44,106,000 kg CO2e. This figure includes 8,186,000 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and 3,378,000 kg CO2e from Scope 2 emissions, representing indirect emissions from the generation of purchased electricity, steam, heating, and cooling. The majority of their emissions, about 32,542,000 kg CO2e, fall under Scope 3, which encompasses all other indirect emissions in the value chain. Comparatively, in 2022, their total emissions were around 29,066,000 kg CO2e, with Scope 1 at 7,017,000 kg CO2e, Scope 2 at 3,977,000 kg CO2e, and Scope 3 at 18,072,000 kg CO2e. The increase in emissions from 2022 to 2023 indicates a significant rise in their carbon footprint. Despite the lack of specific reduction targets or initiatives disclosed, Sunrise Medical's commitment to addressing climate change is evident through their emissions reporting. The company is positioned within an industry increasingly focused on sustainability and reducing carbon emissions, aligning with global efforts to combat climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2021 | 2022 | 2023 | |
|---|---|---|---|
| Scope 1 | 4,502,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 3,784,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 17,855,000 | 00,000,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Sunrise Medical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
